Ordering Recommendation

May be useful to evaluate if etiology of hypoglycemia is exposure to sulfonylurea hypoglycemic drugs. Serum or plasma is the preferred specimen; refer to Hypoglycemia Panel (Sulfonylureas), Serum or Plasma (3005636).

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Random urine.

Specimen Preparation

Transfer 5 mL urine to ARUP Standard Transport Tubes. (Min: 1.2 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.

Storage/Transport Temperature

Refrigerated. Also acceptable: Frozen

Unacceptable Conditions
Remarks
Stability

Ambient: 72 hours; Refrigerated: 2 weeks; Frozen: 6 months

Methodology

Quantitative Liquid Chromatography-Tandem Mass Spectrometry

Performed

Varies

Reported

5-12 days

Reference Interval

By report

Interpretive Data



Compliance Category

Performed by non-ARUP Laboratory

Note

Hotline History

N/A

CPT Codes

80377 (Alt code: G0480)

Components

Component Test Code* Component Chart Name LOINC
0090833 Chlorpropamide, Urine 12396-8
0090913 Tolazamide, Urine 6951-8
0090914 Tolbutamide, Urine 6952-6
0090918 Glyburide, Urine 6945-0
0090927 Glipizide, Urine 6944-3
0090928 Acetohexamide, Urine 27164-3
2005825 Glimepiride, Urine 73691-8
2005826 Nateglinide, Urine 73690-0
2005827 Repaglinide, Urine 73689-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Meglitinides
Sulfonylurea Hypoglycemia Panel, Quantitative, Urine

Medtox